国际标准期刊号: E-2314-7326
P-2314-7334

神经传染病

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 出租车直达
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • ICMJE
分享此页面

抽象的

Total Lymphocyte Count Analysis and Nutritional Status of Patients for Tuberculous Meningitis Patient Outcomes

Dominggo Theodoran Girsang1*, Dimas Erlangga Luftimas2,3 and Sofiati Dian4,5

Introduction: Tuberculous Meningitis (TBM) is a manifestation of extra-pulmonary TB that causes inflammation of the meninges. TBM is also known as the deadliest form of TB disease. Malnutrition is one factor that increases the risk of severity and death of TB patients. In this study, we aimed to analyse the Total Lymphocyte Count (TLC) as a nutritional biomarker in TBM patients as a predictor of mortality by logistic regression technique to determine the effect of each variable on the outcome.

Methods: This study is a multivariate analytic study using secondary data. A bivariate correlation test analysed all the independent variables. Afterwards, the significant variable(s) were analysed independently by logistic regression to predict the best model for adverse patient outcomes. This study used 95% confidence intervals (CI), and variables with a significance value of p <0.05 were considered significant.

Results: A total of 209 patients' medical records were analysed in this study. The patients consisted of 105 males and 104 females ranging from 17-74 years old, with an average of 34 years old and median of 32 years old. Out of these, 53 patients (25.4%) died, and 156 patients (74.6%) were alive. In this present study, showed age (p = 0.002), hospitality duration (p <0.001), GCS (p = 0.032) and TLC (p <0.001) were independent predictors of death patient outcome.

Conclusion: In summary, our study showed that the TLC is a promising biomarker for TBM patients' outcomes and coinciding with patient characteristics, we can improve its predictive value. TLC is also known as a nutritional biomarker; thus, nutritional management is crucial to improve the outcome of TBM patients.